Taormina, Italy
April 21 - April 22, 2002
Quality of life has become a very important issue in deciding the extent of surgical procedures for patients affected with a variety of cancers. As cancer treatment has improved the rate of survival associated with several neoplasias, cancer survivors are more and more interested in preserving fertility potential.
This program focused on new and innovative techniques or approaches to treat male and female cancers while minimizing the negative fertility effects of such treatment.
OBJECTIVES
At the conclusion of this program the participants were able to:
- Cite evidence for the cryopreservation of semen, ovarian tissue, testicular tissue, and/or embryos in the preservation of fertility in oncology patients.
- Determine pregnancy outcome after cryopreservation and autotransplantation.
- Identify the variables involved when advising patients about options.
- Analyze potential future treatments currently being explored in both animals and humans.
TARGET AUDIENCE
The Symposia is open to gynecologists, embryologists and andrologists working in the field of assisted reproduction. Oncologists, urologists and general clinicians are also encouraged to attend.
Serono Symposia International is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.be.
"Fertility Preservation in Cancer Patients" was designated for a maximum of 14 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
EACCME credits are recognized as Physician’s Recognition Award by the American Medical Association.
Application for CME credits was made to the Royal College of Physicians London, UK.
